2021 MedCan Speaker

Dr. Adele Hosseini, PhD

Chief Scientific Officer,
Bod Australia

Dr. Adele Hosseini, Chief Scientific Officer at Bod Australia, has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues to development of new strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit.

All Sessions by Dr. Adele Hosseini, PhD

Day 1 - Industry Summit - 10 February

Time Science Stream
  • Making the business case for commercialising medicinal cannabis whilst adhering to the regulations – how can this be achieved effectively?
  •  Understanding methodological innovations required when undertaking Research on cannabis

Dr. Adele Hosseini, PhD 
Chief Scientific Officer, Bod Australia

More Speakers

Anna Yallop

General Manager

Richard Keene


Imche Fourie

Co-Founder & CEO

Graham Gulbransen

Cannabis Consultant, Addiction Specialist, General Practitioner